Mitigating the Risk from Excipient Variability
This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing
August 3rd 2022This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Vaccine Administration: The Growing Role of Prefilled Syringes
August 3rd 2022The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.